Oligodendrocyte precursor cells present antigen and are cytotoxic targets in inflammatory demyelination.
Animals
Antigen-Presenting Cells
/ immunology
Antigens
/ immunology
Astrocytes
/ metabolism
CD4-Positive T-Lymphocytes
CD8-Positive T-Lymphocytes
Caspase 3
/ metabolism
Caspase 7
/ metabolism
Cell Differentiation
Central Nervous System
/ immunology
Cytokines
/ genetics
Demyelinating Diseases
/ immunology
Disease Models, Animal
Gene Expression
Histocompatibility Antigens Class I
Humans
Interferon-gamma
Mice
Mice, Inbred C57BL
Mice, Transgenic
Multiple Sclerosis
/ immunology
Myelin Sheath
/ metabolism
Oligodendrocyte Precursor Cells
/ drug effects
Oligodendroglia
/ metabolism
Ovalbumin
/ metabolism
Remyelination
/ immunology
T-Lymphocytes
Journal
Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555
Informations de publication
Date de publication:
29 08 2019
29 08 2019
Historique:
received:
01
11
2018
accepted:
24
07
2019
entrez:
31
8
2019
pubmed:
31
8
2019
medline:
7
1
2020
Statut:
epublish
Résumé
Oligodendrocyte precursor cells (OPCs) are abundant in the adult central nervous system, and have the capacity to regenerate oligodendrocytes and myelin. However, in inflammatory diseases such as multiple sclerosis (MS) remyelination is often incomplete. To investigate how neuroinflammation influences OPCs, we perform in vivo fate-tracing in an inflammatory demyelinating mouse model. Here we report that OPC differentiation is inhibited by both effector T cells and IFNγ overexpression by astrocytes. IFNγ also reduces the absolute number of OPCs and alters remaining OPCs by inducing the immunoproteasome and MHC class I. In vitro, OPCs exposed to IFNγ cross-present antigen to cytotoxic CD8 T cells, resulting in OPC death. In human demyelinated MS brain lesions, but not normal appearing white matter, oligodendroglia exhibit enhanced expression of the immunoproteasome subunit PSMB8. Therefore, OPCs may be co-opted by the immune system in MS to perpetuate the autoimmune response, suggesting that inhibiting immune activation of OPCs may facilitate remyelination.
Identifiants
pubmed: 31467299
doi: 10.1038/s41467-019-11638-3
pii: 10.1038/s41467-019-11638-3
pmc: PMC6715717
doi:
Substances chimiques
Antigens
0
Cytokines
0
Histocompatibility Antigens Class I
0
Interferon-gamma
82115-62-6
Ovalbumin
9006-59-1
Casp3 protein, mouse
EC 3.4.22.-
Caspase 3
EC 3.4.22.-
Caspase 7
EC 3.4.22.-
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
3887Subventions
Organisme : NINDS NIH HHS
ID : P30 NS050274
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS096148
Pays : United States
Organisme : NICHD NIH HHS
ID : U54 HD083091
Pays : United States
Organisme : NINDS NIH HHS
ID : R37 NS041435
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM008752
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS041435
Pays : United States
Références
Brain. 2006 May;129(Pt 5):1306-18
pubmed: 16504972
Glia. 2017 Dec;65(12):2087-2098
pubmed: 28940645
Annu Rev Immunol. 1996;14:207-32
pubmed: 8717513
J Clin Invest. 2006 Dec;116(12):3252-7
pubmed: 17099776
Science. 1994 Jul 22;265(5171):528-30
pubmed: 7518614
Cell. 2018 Nov 29;175(6):1679-1687.e7
pubmed: 30343897
J Neurol Sci. 1973 Sep;20(1):63-72
pubmed: 4744511
J Neurol Sci. 1983 Dec;62(1-3):219-32
pubmed: 6607973
Curr Opin Immunol. 2010 Feb;22(1):109-17
pubmed: 20171863
Curr Opin Immunol. 2009 Feb;21(1):98-104
pubmed: 19217269
Cold Spring Harb Perspect Biol. 2015 Aug 20;8(2):a020453
pubmed: 26492571
Biochim Biophys Acta. 2011 Feb;1812(2):151-61
pubmed: 20637863
Nat Rev Immunol. 2012 Jul 13;12(8):557-69
pubmed: 22790179
Immunity. 2010 Mar 26;32(3):414-25
pubmed: 20303295
Glia. 2005 Nov 1;52(2):127-43
pubmed: 15920731
Immunity. 2002 Aug;17(2):211-20
pubmed: 12196292
Cell. 1994 Jan 14;76(1):17-27
pubmed: 8287475
Immunity. 2015 Sep 15;43(3):502-14
pubmed: 26341401
Nat Med. 2018 Dec;24(12):1837-1844
pubmed: 30420755
J Vis Exp. 2016 Feb 17;(108):53764
pubmed: 26967760
Nat Neurosci. 2017 May;20(5):674-680
pubmed: 28288125
Stem Cell Res. 2012 Nov;9(3):208-17
pubmed: 22885102
Brain Pathol. 2001 Jan;11(1):107-16
pubmed: 11145196
Trends Neurosci. 2002 Jun;25(6):313-9
pubmed: 12086750
J Neurosci Res. 1998 Apr 15;52(2):230-9
pubmed: 9579413
Nat Neurosci. 2013 Sep;16(9):1211-1218
pubmed: 23872599
Nat Commun. 2017 May 31;8:15508
pubmed: 28561022
J Immunol. 2001 Mar 1;166(5):3218-25
pubmed: 11207275
Neuron. 2010 Nov 18;68(4):668-81
pubmed: 21092857
Immunity. 1997 Jun;6(6):715-26
pubmed: 9208844
Nature. 2019 Feb;566(7745):543-547
pubmed: 30747918
Nat Neurosci. 2013 Jun;16(6):668-76
pubmed: 23624515
Brain. 1999 Dec;122 ( Pt 12):2279-95
pubmed: 10581222
J Invest Dermatol. 2000 Sep;115(3):449-53
pubmed: 10951282
Annu Rev Immunol. 2002;20:323-70
pubmed: 11861606
Nature. 1993 Jan 28;361(6410):359-62
pubmed: 7678924
Nature. 2011 Apr 21;472(7343):319-24
pubmed: 21389984
Immunol Cell Biol. 2000 Apr;78(2):110-7
pubmed: 10762410
Neuron Glia Biol. 2009 Nov;5(3-4):35-44
pubmed: 19785924
Annu Rev Immunol. 2013;31:443-73
pubmed: 23298205
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Clin Exp Rheumatol. 2015 Jul-Aug;33(4 Suppl 92):S74-9
pubmed: 26458097
J Neurosci. 2000 Sep 1;20(17):6404-12
pubmed: 10964946
Adv Immunol. 2002;80:1-70
pubmed: 12078479
Immunity. 2017 Feb 21;46(2):245-260
pubmed: 28228281
Nat Immunol. 2004 Jun;5(6):606-14
pubmed: 15146180
J Exp Med. 1996 Dec 1;184(6):2361-70
pubmed: 8976190
J Exp Med. 2003 May 5;197(9):1073-81
pubmed: 12732654
Glia. 2010 Jan 15;58(2):195-208
pubmed: 19606498
Handb Clin Neurol. 2014;122:15-58
pubmed: 24507512
J Neurosci. 2007 Feb 21;27(8):2013-24
pubmed: 17314297
Nature. 1994 Aug 25;370(6491):650-2
pubmed: 7520535
Cell. 1997 Feb 7;88(3):355-65
pubmed: 9039262
Nature. 1994 May 5;369(6475):31-7
pubmed: 8164737
Cell. 1996 Jun 14;85(6):803-15
pubmed: 8681376
Crit Rev Immunol. 2005;25(3):161-82
pubmed: 16048434
Nat Immunol. 2013 Mar;14(3):254-61
pubmed: 23291597
Cell Death Differ. 2014 Aug;21(8):1198-208
pubmed: 24658399
J Neurosci. 2004 Nov 10;24(45):10074-83
pubmed: 15537876
Nature. 1995 Oct 5;377(6548):446-8
pubmed: 7566124
Nat Immunol. 2011 Jun;12(6):560-7
pubmed: 21516112
J Immunol. 2007 Jun 15;178(12):7932-42
pubmed: 17548631
Nat Neurosci. 2006 Dec;9(12):1506-11
pubmed: 17099706
Nat Neurosci. 2013 Oct;16(10):1401-8
pubmed: 23995070
J Neurochem. 1992 Nov;59(5):1770-7
pubmed: 1383426
Nat Neurosci. 2001 Nov;4(11):1116-22
pubmed: 11600888
J Exp Med. 2000 Aug 7;192(3):393-404
pubmed: 10934227
Brain. 1997 Aug;120 ( Pt 8):1461-83
pubmed: 9278635
J Neurosci. 2015 Jun 3;35(22):8626-39
pubmed: 26041928